Hematocrit Increase, Reduced Death in Hypogonadal Men: Implications of Testosterone Therapy (TTh) on Anemia and Complete Blood Count and Paradigm Shift of its Risk Factor

Abstract

Listen

Translate article

Intervention with Testosterone treatment for up to 18 years, in a prospective data collection shows that long-term treatment with testosterone has significant reduction in mortality [1-3] and increase of hematocrit, which theoretically could increase risk of cardiovascular events, could not be proven [4]. Summarizing results of research results that aimed to throw the light on the relationship between hematocrit and all-cause mortality in men receiving Testosterone therapy in long-term setting [5,6].